Robert C. Bast Jr. · American physician-scientist · YYNN

Robert C. Bast Jr.

? TBD

American physician-scientist

Ratings
0

Nobody has rated this yet. Be the first!

Works
5

Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop

scientific article published in November 2007

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women

scientific article published on 17 July 2020

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

scientific article published on 21 May 2008

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Guidelines for the use and interpretation of assays for monitoring autophagy

scientific article

Lists
0

Robert Clinton Bast Jr., (born December 8, 1943) is an American physician-scientist who is the Director of Translational Research Career Development at University of Texas MD Anderson Cancer Center and holder of the Harry Carrothers Wiess Distinguished University Chair. Bast is best known for the discovery of CA125, a serum biomarker for ovarian...

Websitefaculty.mdanderson.org

Instance of

Occupation

Wikidata